Frankfurt - Delayed Quote EUR
ImmunityBio, Inc. (26CA.F)
2.6350
-0.0110
(-0.42%)
As of 8:05:01 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 654.1M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SOON-SHIONG PATRICK Officer, Director and Beneficial Owner | -- | Direct | -- | Feb 21, 2025 |
| SIMON BARRY J. M.D. Director | -- | Direct | -- | Feb 21, 2025 |
| ADCOCK RICHARD Chief Executive Officer | -- | Direct | -- | Feb 21, 2025 |
| SACHS DAVID C Chief Financial Officer | -- | Direct | -- | Feb 21, 2025 |
| LAUER REGAN J Officer | -- | Direct | -- | Feb 21, 2025 |
| SIMON BARRY J. M.D. Director | Conversion of Exercise of derivative security at price 2.00 per share. | Direct | 219,864 | Jan 22, 2025 |
| ADCOCK RICHARD Chief Executive Officer | -- | Direct | -- | Dec 31, 2024 |
| SACHS DAVID C Chief Financial Officer | -- | Direct | -- | Dec 31, 2024 |
| LAUER REGAN J Officer | -- | Direct | -- | Dec 13, 2024 |
| SOON-SHIONG PATRICK Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security at price 1.94 - 2.28 per share. | Indirect | 231,402,412 | Dec 10, 2024 |
| ADCOCK RICHARD Chief Executive Officer | -- | Direct | -- | Feb 5, 2024 |
| SIMON BARRY J. M.D. Director | -- | Direct | -- | Jan 31, 2024 |
| SACHS DAVID C Chief Financial Officer | -- | Direct | -- | Jan 31, 2024 |
| LAUER REGAN J Officer | -- | Direct | -- | Jan 31, 2024 |
| ADCOCK RICHARD Chief Executive Officer | -- | Direct | -- | Dec 29, 2023 |
| SACHS DAVID C Chief Financial Officer | -- | Direct | -- | Dec 29, 2023 |
| LAUER REGAN J Officer | -- | Direct | -- | Dec 15, 2023 |
| SIMON BARRY J. M.D. Director | -- | Direct | -- | Sep 1, 2023 |
| SACHS DAVID C Chief Financial Officer | -- | Direct | -- | Sep 1, 2023 |
| LAUER REGAN J Officer | -- | Direct | -- | Sep 1, 2023 |
Related Tickers
2LB.F Iovance Biotherapeutics, Inc.
1.8930
-2.03%
UP0.F Ultragenyx Pharmaceutical Inc.
32.20
-3.59%
38I.F Intellia Therapeutics, Inc.
6.98
+2.71%
2L9.F Blueprint Medicines Corporation
110.30
+1.19%
4DN.MU Denali Therapeutics Inc.
12.73
-1.36%
ALNEV.PA Neovacs S.A.
0.0034
+13.33%
ESLA Estrella Immunopharma, Inc.
0.9600
-4.95%
VIRX Viracta Therapeutics, Inc.
0.0200
0.00%
DWTX Dogwood Therapeutics, Inc.
4.6500
-11.09%
TVGN Tevogen Bio Holdings Inc.
1.2400
-2.36%